Material
T he Gram-negative Haemophilus influenzae belongs to the Pasteurellaceae family and is part of the normal flora in the human nasopharynx. During certain conditions when the defenses are reduced or exhausted because of a simultaneous viral infection, H. influenzae can progress from a commensal to a true pathogen (1, 2). The outer surface of H. influenzae varies and is characterized by the presence or absence of a polysaccharide capsule that constitutes the basis for classification. Encapsulated strains display six different types of polysaccharide capsules (serotypes a to f) (3, 4) , whereas H. influenzae isolates lacking the polysaccharide structure are named nontypeable H. influenzae (NTHi).
The array of disease caused by H. influenzae is highly variable with a marked difference between NTHi and the encapsulated counterparts. Encapsulated H. influenzae, particularly H. influenzae type b (Hib), are usually involved in more invasive diseases such as meningitis, epiglottitis, or septicemia (1) . In contrast, NTHi are often associated with acute otitis media, sinusitis and are responsible for exacerbations in patients suffering from chronic obstructive pulmonary disease or cystic fibrosis (2, 5, 6) . After introduction of the Hib vaccine in the early 1990s, which has successfully abrogated Hib infections, the incidence of other non-Hib H. influenzae, in particular NTHi and serotype f (Hif), has steadily increased as reported in several countries of the Western world (7) (8) (9) .
The capacity of bacteria to infect a host relies on the ability of the microorganism in question to evade the host immune system. The complement system, an important component of the innate immunity, is a part of the first line of defense for pathogens to overcome in mammals. It is subdivided into three pathways: the classical pathway, the lectin pathway, and the alternative pathway triggered by three distinct mechanisms. These pathways converge in the formation of the C3 and C5 convertases, followed by the terminal pathway and finally generation of the membrane attack complex (MAC) (10) . To avoid the inappropriate riddance of healthy host cells, a plethora of complement inhibitors, either soluble or surface bound, acts specifically at different levels of the cascade (10, 11) . Although their targets are different, the mechanism of action of the soluble regulators is similar; they cluster at the surface of host cells and locally inhibit the action of complement (12, 13) . Regulation of the alternative pathway is achieved by two soluble molecules, that is, factor H (FH) and FH-like protein 1 (FHL-1) (14) . FH and FHL-1 act as cofactors for factor I in the degradation of C3b, inhibit the formation, and accelerate the decay of the C3 convertase of the alternative pathway (14) . FH is a 150-kDa soluble protein consisting of 20 short consensus repeats (SCRs) of ∼60 aa. FHL-1 (42 kDa) is processed by alternative splicing of the FH transcript and is composed of the seven first SCRs of FH and four unique amino acids (15) . Each SCR or group of SCRs are involved in different functions. The first four SCRs are responsible for regulating the C3 convertase of the alternative pathway (16) , whereas SCRs 19-20 are responsible for interaction with host cell surfaces, and SCRs 7, 9, and 19-20 have the ability to interact with polyanions, including heparin and sialic acid (13, 17, 18) .
Similarly to many other bacterial species, H. influenzae relies on a multifaceted strategy to evade the action of complement including modifications of the lipooligosaccharide (LOS) structure, presence of a polysaccharide capsule in encapsulated H. influenzae, and recruitment of complement regulators at the bacterial surface (19) . H. influenzae has been shown to escape serum-mediated killing by binding FH and C4b-binding protein, the latter governs the classical pathway of complement activation, but also vitronectin, which results in inhibition of the terminal pathway and formation of the MAC (19) (20) (21) (22) (23) .
Several pathogens bind FH as a strategy to efficiently combat the complement system. The recruitment of human FH by bacteria has been proven to be mediated by two types of molecules: sialic acid decorating the LOS as in Neisseria meningitidis and N. gonorrheae (24, 25) and/or surface proteins with specific affinity for FH (12, 13, 26) . The latter phenomenon is used by a large group of bacteria, and it is highly interesting to notice that the FH-binding proteins uncovered so far belong to different families and harbor very few sequence homologies.
We previously showed that H. influenzae binds to human FH and that this interaction is mediated at least partly by one or several surface-exposed proteins (21) . In the current study, our goal was to unveil the proteins underlying the interaction between H. influenzae and FH by extracting outer membrane proteins (OMPs) of strong FH-binding strains and using FH as bait. A unique protein of ∼34 and 35 kDa in Hib and Hif, respectively, was found to display an affinity for FH and was consequently named protein H (PH). We further show that PH is the main actor promoting H. influenzae-dependent interaction with FH and that the PH molecule is ubiquitously expressed as a surface-exposed protein in an array of Hib and Hif clinical isolates. Importantly, we demonstrate that deletion of the gene encoding PH results in a reduced survival upon exposure to the bactericidal activity of human serum, suggesting that FH binding is important for H. influenzae virulence.
Materials and Methods

Bacterial strains and culture conditions
All H. influenzae strains (Table I) were grown overnight on chocolate agar plates at 37˚C with 5% CO 2 . Liquid cultures were propagated in brain heart infusion (BHI) broth complemented with 10 mg/ml hemin (SigmaAldrich, St. Louis, MO) and 10 mg/ml NAD (Sigma-Aldrich) (supplemented BHI [sBHI]) at 180 rpm shaking. Escherichia coli BL21 strains were grown on Luria-Bertani (LB) agar plates with or without 50 mg/ml kanamycin at 37˚C for 16 h. Bacteria were cultured in LB supplemented with 50 mg/ml kanamycin when required at 200 rpm shaking at 37˚C. The production of recombinant proteins were induced by addition of 0.5 mM isopropyl b-D-thiogalactoside (Saveen and Werner, Limhamn, Sweden) at OD 600 = 1.0.
Extraction of OMPs and two-dimensional gel electrophoresis
Bacterial OMP fractions were prepared from overnight cultures based upon the method of Alteri and Mobley (27) . OMPs (1 mg) were incubated with 50 U benzonase (Sigma-Aldrich) and solubilized in 400 ml of freshly prepared rehydration buffer ( [4] [5] [6] [7] [GE Healthcare Life Sciences], 1 mM phenylmethanesulfonylfluoride [USB, Affymetrix, Santa Clara, CA], and 4 mM (2-aminoethyl) benzenesulfonyl fluoride hydrochloride [Sigma-Aldrich]). Thereafter, overnight in-gel rehydration was done on a precast 7 cm (pH 4-7) immobilized pH gradient gel strip (Immobiline Drystrips; GE Healthcare Life Sciences). First dimension separation by isoelectric focusing was performed on an IPGphor II electrophoresis unit (GE Healthcare Life Sciences), followed by a second dimension of gel electrophoresis on 12% SDS-PAGE as described previously (23) . Protein spots on gels were visualized by silver staining (Bio-Rad, Hercules, CA) for image analysis, and alternatively with Coomassie blue staining for protein identification with mass spectrometry. Gels were scanned on a ChemiDoc XRS+ System (Bio-Rad) and analyzed with Image Lab Software (Bio-Rad). Targeted protein spots were manually excised and protein identification by MALDI-TOF-mass spectrometry was performed by Protein Analysis Service available at Alphalyse (Odense, Denmark).
Protein electrophoresis, Western blotting, and far-Western blotting
Protein samples were denatured at 95˚C for 5 min in a loading buffer (50 mM Tris-HCl, 2% SDS, 10% glycerol, and 100 mM DTT [pH 6.8]) and separated on an SDS-PAGE using a Mini Protean II system (Bio-Rad) at 110 V (28 
Production and purification of recombinant PH
The genes encoding the FH-binding protein (lph) in H. influenzae serotype b (Hib lph) and serotype f (Hif lph) were amplified by PCR excluding the 63 initial nucleotides encoding for the signal peptide. The reaction mixture contained genomic (g) DNA from strains Hib 541 or Hif KR494 (Supplemental Table I ), primers lph_F1 and lph_R1 for Hib (Supplemental Table I ), or primers lph_F2 and lph_R2 for Hif in addition to Phusion polymerase (Thermo Scientific, Waltham, MA). The genes were cloned into pET26b linearized with BamHI and XhoI (Fermentas, Gothenburg, Sweden) to yield plasmids pET26lphb and pET26lphf (Supplemental Table I ), which were transformed into E. coli BL21 (DE3) (Novagen, Darmstadt, Germany). Positive transformants were selected on LB agar plates containing 50 mg/ml kanamycin. Protein production was performed by growing selected clones in LB at 37˚C, 200 rpm shaking. The histidinetagged recombinant proteins were purified by immobilized nickel ion affinity chromatography (Histrap FF; GE Healthcare) following the manufacturer's instruction. After elution, proteins were dialyzed against PBS (pH 7.5), quantified using bicinchoninic acid (Pierce), and controlled on SDS-PAGE. The Abs were generated as previously described (23) and purified by affinity on protein A-Sepharose (GE Healthcare) following the manufacturer's recommendations.
ELISA
The interaction between PH and FH was analyzed by ELISA. Recombinant PH (of the type b and type f, respectively) were immobilized overnight (4˚C) in Polysorb microtiter plates (Nunc, Roskilde, Denmark). Plates were washed with PBS containing 0.1% Tween 20 (PBST) and blocked for 1 h at room temperature with PBSO. FH at increasing concentrations (0.1-50 nM) diluted in PBSO were added to each well in triplicates and incubated for 1 h at room temperature. After extensive washing with PBST, bound FH was detected using a mouse anti-FH mAb, followed by HRPconjugated goat anti-mouse IgG. The reactions were developed by addition of 20 mM tetramethylbenzidine and 0.1 M potassium citrate, and absorbance was read at OD 450 . Recombinant fragments of FH (SCRs 1-5, 1-6, 8-11, 8-20, 15-18, 15-19, 18-20, and 19-20) and FHL-1 (SCRs 1-7) were expressed in a baculovirus system or in Pichia pastoris as described previously (29) . Microtiter plates (F96 Maxisorb; Nunc-Immuno Module) were coated with PH (5 mg/ml) or gelatin (5 mg/ml) overnight at 4˚C. The plates were washed four times with PBST and blocked for 1 h with PBS supplemented with 2% BSA (PBS-BSA). After washing, the plates were incubated for 1 h at room temperature with FH and equimolar amounts of the various FH constructs (0.13 mM). Thereafter, the wells were washed and goat anti-human FH pAb was added, followed by addition of HRPconjugated rabbit anti-goat pAb for 40 min at room temperature. Reactions were developed with 1,2-phenylenediamine dihydrochloride (DakoCytomation), and the absorbance was measured at OD 492 .
Construction of lph deletion mutants
Isogenic lph deletion mutants were achieved by replacing the initial 650 bp of the gene (locus HIB_11110 in Hib 10810 and locus HifGL_000598 in Hif KR494) by homologous recombination in Hib 541 and Hif M10 (Supplemental Fig. 1 ). The final 200 bp of the genes were retained because bioinformatics analysis performed by BProm software (http://www. softberry.com) predicted this region to contain putative regulatory elements of a promoter for the gene located immediately downstream of lph. The transformation cassettes were constructed by independently amplifying by PCR the upstream and downstream regions flanking lph and the chloramphenicol acetyltransferase (cat) gene and finally merging the three PCR products together by ligation and joining PCR. Amplification of the cat gene was performed by using primers Cat_F and Cat_R and the plasmid pLysS (EMD Biosciences, Darmstadt, Germany) as a template. Regions flanking the lph gene were separately amplified by mixing gDNA and a combination of primers to amplify the Hib upstream flanking region (lph_UFF and lphB_UFR), the Hib downstream flanking region (lphB_ DFF and lph_DFR), the Hif upstream flanking region (lph_UFF and lphF_UFR), or finally the downstream flanking region (lphF_DFF and lph_DFR). The lph upstream flanking regions and the cat resistance gene were fused by a joining PCR in a reaction containing an equimolar concentration of DNA fragments, primers lph_UFF and Cat_R. The final product was purified and merged with the downstream flanking region by ligation after an initial digestion by XhoI. Transformation was performed as described below and the resulting strains were designated HibDlph and HifDlph.
Transmission electron microscopy
To ensure that gene deletion of lph and consequently loss of PH production would not result in alterations of the cell wall, bacterial strains were also subjected to transmission electron microscopy (Supplemental Fig. 2A-D ). Bacteria were grown on chocolate agar and fixed in 2.5% glutaraldehyde in 0.1 M sodium cacodylate overnight. Thereafter, bacteria were rinsed in 0.1 M sodium cacodylate for 15 min and postfixed in 1% osmiumtetroxide for 2 h. Bacteria were dehydrated in a graded ethanol series during 2 h, and the residual water was removed with propylene oxide for 30 min prior to embedding in Spurr's resin (EMS) overnight. Bacteria in Spurr's resin was polymerized at 65˚for 8 h. Ultrathin sections (80 nm) were obtained on a ultramicrotome (Leica EM UC7) with a diamond knife (45˚; Diatome) and counterstained with uranyle acetate and lead citrate on formar-coated nickel grids. The samples were examined on a JEM1230 transmission electron microscope (JEOL) operating at 80 kV at 325,000 and 3150,000 magnifications. Micrographs were recorded with a Gatan MSC 600CW 2000 charge-coupled device camera using the Digital Micrograph software.
Production of transcomplemented HibDlph and knockin strains NTHilphb and NTHilphf
The strains NTHilphb and NTHilphf expressing Hib PH and Hif PH, respectively, were generated by chromosomally inserting Hib lph or Hif lph, respectively, into the locus CGSHi3655_06559 in NTHi 3655 (30, 31) (Supplemental Fig. 1 ). The control strain NTHi 7.3 transformed by an empty cassette containing only the resistance gene nptI also was generated to account for the variations derived from the disruption of the locus CGSHi3655_06559. The strong promoter of the H. influenzae protein 5 (P5) encoding gene (Pp5; CGSHi3655_06069) was amplified by PCR with primers P5Pro_F and P5Pro_R and ligated into the plasmid pKR7 to yield pKR7.3. Each lph gene was amplified from the parental strain (Hib 541 and Hif KR494) by PCR in a reaction mixture containing primers lphB_F1 and lph_R3 (Hib) and lphF_F1 and lph_R3. Genes were inserted into pKR7.3 to yield the plasmids pKR7.3lphb and pKR7. 3lphf (Supplemental Table I ). Transcomplementation of the lph gene was performed in HibDlph by stable genomic insertion of lph in the locus HIB_08720 (Hib 10810 genome) (ilvA) to yield the strain HibDlphcom. A control strain Hib 21.3 also was created by insertion in the same locus of nptI. A vector containing the intergenic HIB_08720 was constructed as previously described to yield pKR21 (30) . The multiple cloning sites and the nptI gene were amplified by PCR using pKR7.3 as a template with primers PP5_ilvA_F and PP5_ilvA_R and inserted in the ilvA gene fragment in pKR21 by overlap extension PCR cloning to yield pKR21.3 (32) . Hib lph and its promoter were amplified by PCR from Hib 541 gDNA in a reaction mixture containing primers PlphB_F and lph_R3 and ligated in pKR21.3 to generate pKR21.6lphb. The transformation modules were produced by amplification by PCR of the plasmids using primers KS36 and KS37. The purified PCR products were used to transform H. influenzae by the M-IV method (33) .
Transformation of H. influenzae
H. influenzae strains were transformed with linear DNA using natural transformation as described previously (33) . Transformants were selected on chocolate agar plates containing 4 mg/ml chloramphenicol or 5 mg/ml kanamycin and were further characterized by PCR amplification and sequencing of the modified regions. The presence of PH was ascertained by Western blot with anti-Hib PH or anti-Hif PH antiserum.
Flow cytometry
Bacteria were grown in liquid sBHI to OD 600 = 0.5 and collected by gentle centrifugation. Thereafter, bacteria were incubated on ice for 1 h in the presence of either rabbit anti-Hib PH or rabbit anti-Hif PH pAb. After extensive washing, a FITC-conjugated swine anti-rabbit IgG was added. Bacteria were washed with PBS-BSA before analysis on a FACSCanto (BD Biosciences, Franklin Lakes, NJ) using the software Diva 6.1.1.
FH direct binding assay
Human FH was labeled with [ 125 I] as described previously (21) . Bacteria were cultured in sBHI until OD 600 reached 0.5-1.0 (exponential growth phase), and ∼2 3 10 7 colony forming units (cfu) were incubated with 125 I-labeled FH diluted in PBS containing 2.5% BSA for 1 h at 37˚C. Thereafter, bacteria were pelleted, and the supernatant was collected followed by two washes with PBS-BSA. Finally, the supernatant (unbound fraction) and bacteria (bound FH) were mixed with a scintillator mixture and counted. Binding efficiency was calculated as the proportion of bound particles ([washed bacteria]/bound fraction + unbound [supernatant]).
Cofactor assay
Cofactor activity of Hib or Hif PH-bound FH was performed as described previously (34) . Briefly, microtiter plates were coated with Hib or Hif PH (5 mg/ml) or BSA (5 mg/ml) overnight at 4˚C. Plates were washed four times with PBST and blocked for 1 h with blocking buffer I (Applichem, Darmstadt, Germany). After washing, the plates were incubated for 1 h at room temperature with FH (20 mg/ml). After extensive washing with PBST, C3b (10 mg/ml) and factor I (1.4 mg/ml) were added, and the reactions were terminated by the addition of SDS-PAGE sample buffer (Roti-Load1; Carl Roth, Karlsruhe, Germany). Bacteria (5 3 10 8 ) were incubated with FH (100 mg/ml) in Dulbecco's PBS for 1 h at 37˚C. After thorough washing in Dulbecco's PBS, the bacteria were mixed with 4.8 mg/ml factor I and 2.4 mg/ml C3b and incubated for 1 h at 37˚C. As a positive control, FH was used in fluid phase instead of bacteria incubated with FH. As a negative control, bacteria without FH preincubation were used. The reactions were terminated by the addition of SDS-PAGE sample buffer (Roti-Load1). The samples were subjected to SDS-PAGE, transferred to a nitrocellulose membrane, and analyzed by Western blotting. C3b degradation fragments were visualized by goat anti-human C3 pAb, which was added for 1 h, followed by HRP-conjugated rabbit anti-goat pAb (DakoCytomation) added for 40 min. After additional washing, development was performed with ECL Western blotting detection reagents (Applichem).
Serum bactericidal assay
A serum killing assay was performed as previously described (23) using fresh normal human serum (NHS) obtained from five healthy donors. The serum concentration for optimal killing was determined to be 20 and 5% in the case of Hib 541 and Hif M10, respectively. Each strain was cultured in sBHI until OD 600 reached 0.5-1.0. Bacteria were harvested by centrifugation and resuspended in DGVB++ (2.5 mM Veronal buffer [pH 7.3], 2.5% glucose, 2 mM MgCl 2 , 0.15 mM CaCl 2 , and 0.1% gelatin) to be used in the serum bactericidal assay. Approximately 1500 bacteria were mixed with the appropriate serum concentration in 100 ml final volume. After 20 min incubation at 37˚C, 10 ml of the reaction from three independent tubes were plated on chocolate agar plates. Plates were incubated for 18 h, the number of cfu was manually counted, and the results were expressed as the percentage of cfu at time 20 min using T0 as the 100% reference. Heatinactivated serum (HIS; 56˚C for 30 min) was used as a control and each experiment was performed three times.
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Bioinformatics and statistical analyses
Molecule sequences analyses were performed using CLUSTALW, BLAST, and Pfam HMM Search (http://www.expasy.org). Protein localization (in the outer membrane) was analyzed using CELLO and NetSurfP (35, 36) . Statistics and nonlinear regression analyses were performed using the software PRISM 5.0 (GraphPad Software, La Jolla, CA). The flow cytometry histograms were compiled and drawn with Flowing software Version 2.5.
Results
Identification of H. influenzae PH that interacts with human FH
We previously reported that Hib and Hif clinical isolates more efficiently bind human FH as compared with other encapsulated H. influenzae or NTHi (21) . We chose the strong FH-binding serotypes Hib and Hif to reveal the proteins mediating the interaction between H. influenzae and FH (Table I) . OMPs were extracted from the strains Hib 541 and Hif KR494, followed by separation on twodimensional SDS-PAGE (Fig. 1, upper panels) . FH was used as a probe, and the FH-binding proteins were identified in a farWestern blot immunoassay (Fig. 1, lower panels) . For each H. influenzae strain, we observed a unique spot corresponding to proteins with molecular masses of ∼34 and 35 kDa for Hib 541 and Hif KR494, respectively. High molecular mass OMPs are not resolved properly in two-dimensional SDS-PAGE. Therefore, to detect a possible high molecular mass FH-binding protein, we ran a 7% SDS-PAGE, followed by a far-Western blot applying the same strategy as described for the two-dimensional SDS-PAGE. We did not, however, observe any additional FH-binding proteins and instead confirmed the two 35-and 34-kDa proteins to be the only FHbinding molecules in Hib and Hif (Supplemental Fig. 2E ).
The spots identified as FH-binding proteins were manually excised from the two-dimensional gel (Fig. 1, lower panels) , subjected to trypsin digestion, and finally analyzed by MALDI-TOF. The peptide sequences matched with an unnamed putative protein in Hib 10810 (CBW29298). The corresponding genes encoding these proteins were retrieved to be encoded by loci HIB_11110 in Hib 10810 and HifGL_000598 in Hif KR494. Subsequent sequencing of the encoding gene in Hib 541 showed a 100% identity with the homolog gene found in Hib 10810. Interestingly, these sequences were used to browse the genomes of all available NTHi strains (n = 17 including NTHi3655), but no homologs were found. The absence of a FH-binding protein in NTHi was further verified in a set of clinical isolates by using the same experimental approach as the one described for Hib and Hif (Supplemental Fig.  2F, 2G) .
Protein domain search (Pfam HMM search) predicted the two proteins as lipoproteins belonging to the lipoprotein 5 family (Pfam: PF01298) with a calculated molecular mass including the signal peptide of 31.6 and 29.8 kDa for Hib 541 and Hif KR494, respectively. The difference in molecular masses apparent on the gel was a discrepancy that may suggest posttranslational modifications. Database interrogation with the sequences of Hib and Hif FH-binding proteins did not identify any related proteins with a known function. Pairwise sequence alignment revealed that the two identified FH-binding molecules in Hib and Hif shared only 56% identical amino acids particularly located in the N-terminal and C-terminal regions, whereas the central part of the molecules displayed a high level of heterogeneity (data not shown). As a consequence of the ability of this protein to bind human FH and in the absence of further evidence of another function, we propose the designation PH and its encoding gene lph.
PH is ubiquitously expressed at the surface of Hib and Hif
To study PH expression across various strains, total protein lysates extracted from an equivalent number of bacteria were separated on SDS-PAGE and analyzed by Western blot using specific pAbs directed against either Hib or Hif PH. We observed that all Hib (n = 14) and Hif (n = 12) clinical isolates selected expressed PH, and the molecular mass (∼35 kDa for Hif and 34 kDa for Hib) was as expected (Fig. 2A, 2C ). This observation suggested that PH is ubiquitously expressed in a large number of Hib and Hif strains.
To prove that PH was a surface exposed protein, an in silico topology study was performed followed by flow cytometry analysis of clinical isolates. Hib and Hif PH amino acid sequences were analyzed and found to be surface exposed in theory but not anchored to the membrane with a 100% confidence score (software Cello and NetSurfP). We randomly selected four isolates representing each serotype, incubated bacteria in the presence of antiHib PH or anti-Hif PH pAbs, followed by flow cytometry. Importantly, we observed a shift for all strains as compared with controls incubated with the secondary Ab only (Fig. 2B, 2D) . Thus, 
these results indicated that PH was accessible for the specific anti-PH pAbs, and therefore, PH most likely was located at the bacterial surface.
A decreased FH-binding is observed with Hib and Hif mutants devoid of PH
Because microbial interactions with FH can be mediated concurrently by several molecules as exemplified in N. meningitidis and N. gonorrheae (37), we wanted to determine the relative importance of PH in the interaction between FH and H. influenzae. Therefore, a set of H. influenzae lph gene deletion mutants were constructed (HibDlph and HifDlph) as well as a transcomplemented mutant of HibDlph (HibDlphcom) (Supplemental Fig. 1 ). Deletion of PH in mutants and restored expression in the transcomplemented counterpart was verified by analysis of total protein content by Western blot as well as flow cytometry using polyclonal anti-PH Abs (Fig. 3A, 3C ). The binding of FH to the Hib mutant devoid of PH was measured by incubation with 125 Ilabeled FH (Fig. 3B) . We found that the bound FH decreased from 17.0 6 2.3% (mean 6 SD) in the Hib wild-type to 2.3 6 0.7% in HibDlph. The transcomplemented mutant HibDlphcom displayed a partially restored phenotype with 10.9 6 0.5% of FH bound as compared with 1.6 6 0.08% for the control HibDlph 21.3. This partially restored phenotype could be explained by a lower PH expression level as revealed by flow cytometry (Fig. 3A) . Similar results were obtained with deletion of PH in Hif as outlined in Fig. 3D . Importantly, the reduced FH binding in lph-knockout mutants was not caused by possible cell wall destruction upon PH depletion because we observed intact cell walls in both wild-type and gene-deletion mutants when bacteria were subjected to transmission electron microscopy (Supplemental Fig. 2A-D) . On the basis of our results, we propose that PH plays a major role in Hiband Hif-dependent FH binding.
To further shed light upon FH-binding to PH, we engineered knockin lph mutants in non-FH-binding NTHi 3655 by chromosomally inserting Hib lph and Hif lph by homologous recombination (Supplemental Fig. 1B) . Analysis of PH expression in the resulting strains NTHilphb and NTHilphf using specific pAbs confirmed the production of both PH and their localization as surface exposed proteins (Fig. 4A, 4B) . Moreover, FH binding was analyzed by incubating PH-expressing NTHi with 125 I-labeled FH. As can be seen in Fig. 4C , NTHi strains expressing the two different PH displayed an increased affinity for FH resulting in 20.8 6 2.8 and 41.4 6 3.2% FH binding for Hib and Hif variants, respectively, when compared with the untransformed NTHi 3655. Taken together, these experiments thus showed that introduction of a single lph gene encoding PH caused a significant increase of FH binding by NTHi. Furthermore, our results suggested a direct interaction between PH and FH and corroborated the results obtained after deletion of PH in Hib and Hif (Fig. 3) .
Recombinant PH derived from Hib and Hif binds FH
Because Hib and Hif PH share only 56% identity at the amino acid level, we further wanted to investigate whether the two PH variants exerted a similar FH binding despite their sequence heterogeneity. To study this in detail, PH from Hib and Hif was expressed as recombinant proteins in E. coli. The interaction between FH and the two recombinant PH was monitored by far-Western blotting (Fig. 5A ). Recombinant PF, an H. influenzae laminin-and vitronectin-binding protein (23) , was included as a negative control and did not bind FH. Recombinant PH derived from Hib and Hif as well as PF and BSA, which were used as negative controls, were also coated on microtiter plates followed by addition of FH and an anti-FH mAb (Fig. 5B) . FH clearly bound to recombinant PH derived from Hib and Hif in ELISA, whereas the negative controls PF and BSA did not bind. The PH-FH interaction was dose-dependent and saturable, and the estimated dissociation constants (K d ) for PH were 1.00 6 0.12 and 0.82 6 0.09 nM for Hib and Hif, respectively. Interestingly, the putative K d of PH derived from Hib or Hif did not significantly differ and may suggest that the affinity for FH of the two PH variants was relatively similar.
We have earlier published (21) that the interaction of H. influenzae with FH is mediated by two distinct regions of FH, that is, SCRs 6-7 and SCRs 18-20. Because we assume and most likely have proven that PH is the main protein interacting with FH in H. influenzae, we hypothesized that PH binds to FH through the same SCRs. Thus, binding of FH deletion mutants to immobilized PH was analyzed by ELISA. The N-terminal SCRs 1-7 (FHL-1) and the C-terminal constructs containing SCRs 8-20 and SCRs 18-20 bound to both Hib and Hif PH (Fig. 5C) The Journal of Immunologythe degradation fragments a9 68, a9 43, and a9 41 kDa. To demonstrate that FH bound to Hib and Hif was functionally active, we analyzed C3b degradation. We observed that FH bound to H. influenzae strains served as a cofactor in the degradation of C3b when Hib (Fig. 6A) and Hif (Fig. 6B) were analyzed. In contrast, when FH was incubated with the deletion mutants HibDlph and HifDlph, the cofactor activity of FH was reduced indicating a lower quantity of FH bound to the mutant bacteria devoid of PH at the surface. Similarly, we found that FH bound to purified recombinant PH derived from Hib or Hif was functionally active as a cofactor in the degradation of C3b (Fig. 6C) . Thus, the interaction of FH with PH did not impair the functional activity of FH.
Because H. influenzae PH mediated recruitment of the alternative pathway regulators FH and FHL-1, and that FH bound to PH retained its complement regulatory activity as a cofactor for factor I in C3b degradation, we expected a correlation between PH and serum resistance. To analyze serum resistance, Hib and Hif strains and their corresponding mutant strains (Fig. 3) were incubated in the presence of NHS at 20 and 5%, respectively. Heat-inactivated normal human serum (HIS) was included as a negative control. Importantly, we found that deletion of lph in either Hib or Hif led to a significant decrease in serum resistance. The Hib wild-type was unaffected by the 20-min exposure to NHS (105 6 3.8% survival), whereas survival of HibDlph was only 9 6 6.8%. Importantly, HibDlphcom exhibited a partially restored serum resistance with 71 6 12% survival at 20 min (Fig. 7A) . Serum survival of the Hif wild-type was slightly reduced to 80.7 6 8.6% upon 10-min exposure to NHS, whereas survival of the lph deletion mutant was significantly lower with only 23.6 6 10.8% bacteria left (Fig. 7B) . These experiments thus proved that the presence of PH at the surface of Hib and Hif played an important role in evasion of complement-mediated killing.
Discussion
H. influenzae resistance to serum killing relies on several mechanisms that includes binding to regulators of the complement system through surface exposed structures or prevention of the activation of complement (19) . In the current study, we identified an H. influenzae surface exposed protein, which mediates the recruitment of FH and FHL-1, the two major regulators of the alternative complement pathway. The new protein designated PH was annotated as a putative protein with unknown function in the Hib 10810 genome. We discovered this protein in two encapsulated Hib and Hif and confirmed that it was expressed in a wide range of Hib and Hif clinical isolates. In silico research of a homolog in NTHi genomes did not yield any positive result suggesting this lipoprotein to be specific for encapsulated H. influenzae. (A and C) , that is, no cross reactivity was observed with the two different anti-PH pAb. For the flow cytometry experiments (B and D), four clinical Hib respective Hif isolates were incubated with the two separate anti-PH pAbs followed by a FITC-conjugated secondary pAb. H. influenzae incubated with the specific anti-PH pAbs (dark gray) displayed a shift as compared with bacteria incubated at the same conditions without the primary anti-PH pAbs (light gray). One representative experiment out of three performed is shown.
PH presents the characteristics of the lipoprotein 5 family (Pfam: PF01298) comprising several members, including the outer membrane lipoprotein (OmlA) from Actinobacillus pleuropneumonie, Neisseria heparin binding Ag (or GNU2132), and the transferrin binding protein B characterized in several bacterial species, including Neisseria spp, Actinobacillus pleuropneumonie, and H. influenzae (38) (39) (40) (41) (42) . The association of transferrin binding protein B with the bacterial outer membrane has been studied more extensively in Neisseria and A. pleuropneumoniae, and in both species, the protein was shown to be tethered to the membrane through the lipid chain inserted on the N-terminal cysteine (41, 43) . This model seems to be applicable to PH, which has been Table I ). Data of the direct binding assay correspond to the mean of three independent experiments, and error bars indicate SD. Statistical significance was assessed by one-way ANOVA. ***p # 0.001. predicted and demonstrated to be exposed at the bacterial surface, but it does not, however, exhibit a typical transmembrane domain.
The deletion of PH in H. influenzae resulted in a complete loss of the bacterial affinity for human FH. This proved that PH is a crucial protein in the interaction between Haemophilus and FH. We further demonstrated that introduction of lph in the non-FHbinding NTHi 3655, resulted in PH expression at the surface that was sufficient to promote an increased recruitment of FH to NTHi. These knockin experiments suggested that the mature PH does not require any partners to be addressed at the surface of NTHi or to interact with FH (see below). Importantly, despite PH is associated with the capsule in encapsulated H. influenzae (Supplemental Fig.  3A-D) , the capsule is not indispensable for expression or localization of PH, as well as its functionality in binding of FH at the bacterial cell surface as shown by the lph knockin NTHi. Because H. influenzae including Hib and Hif produces a capsule that lacks sialic acid (44) (45) (46) , LOS sialylation in both typeable and nontypeable H. influenzae has been reported widely (31, (47) (48) (49) . In contrast to N. gonorrheae and N. meningitides (24, 50) , LOS sialylation does not augment FH-binding in H. influenzae but mediates resistance against the alternative pathway of complement activation by masking the C3 recognition site at the bacterial cell surface (48) . Moreover, we did not observe enhanced FH-binding in the sialylated encapsulated H. influenzae strain Hib 541 and Hif M10 when bacteria were grown in medium supplemented with sialic acid (Supplemental Fig. 3E, 3F) . Depletion of sialic acid from whole cell bacteria with neuraminidase neither reduced the binding of FH. In a nutshell, we showed that the H. influenzae FHbinding was linked to the expression of PH regardless of the presence or absence of a capsule. It also appeared that sialic acid present in the H. influenzae cell wall component LOS does not cocontribute to PH-dependent FH-binding.
Because NTHi lacks PH, but a few strains are able to bind to FH, we were not expecting that the deletion of lph in Hib and Hif would lead to a complete disruption of FH binding, but rather that there would remain a residual affinity for FH due to additional mechanisms (21) . It was recently shown that the interaction between NTHi (strain NT127), but not the interaction between the encapsulated strain RdKW20, and FH is mediated by P5, a protein previously known to be involved in bacterial attachment to mucosal surfaces (51, 52) . This difference between NTHi and H. influenzae type d (RdKW20) is likely due to the sequence variations in P5, and may also account for the lack of affinity for FH observed with the Hib and Hif PH mutants (53, 54) . Two different mechanisms involved in the interaction of H. influenzae with human FH thus exist, one relying on the expression of P5 in NTHi and another one mediated by PH in, at least, Hib and Hif. Several pathogens rely on a comparable multifarious strategy to recruit FH at their surface. In Pseudomonas aeruginosa, Yersinia enterocolitica, Streptococcus pneumoniae, Streptococcus pyogenes, and Borrelia burgdorferi at least two different FH-binding proteins have been characterized, whereas in N. meningitidis, FH recruitment occurs through sialylation of the LOS as well as two separate FH-binding proteins (13, 37, 55) .
Experiments with recombinantly expressed PH from Hib and Hif proved that both variants possessed the ability to interact directly with FH and that the estimated affinity of both molecules for FH was very similar. Moreover, the mapping of PH binding sites on FH showed that both variants possessed two interaction sites, that is, a major binding site located within SCRs 18-20 and a secondary within SCR 7. These observations indicated that the PH variants worked through a conserved mechanism despite sharing only 56% identical amino acids. The region required for binding FH is most likely conserved and the rest of the molecule undergo mutations, probably to escape the recognition by the host innate immune system such as it has been suggested in the case of the meningococcal FH-binding protein (56) . Most bacterial proteins are involved in the acquisition of FH through domains SCRs 6-7 and SCRs 19-20 (13) . Binding to SCRs 6-7 confers at the same time an affinity for FHL-1, whereas interaction with SCRs 19-20 allow the formation of a close tripartite complex with bacteria/FH/C3b, which boosts the degradation of C3b (57, 58) .
At least 10 microbial proteins interact with FH through SCRs 19-20, and the list is steadily expanding. Yet, comparison of PH with bacterial FH-binding proteins did not reveal sequence homologies, thus precluding any deduction about the domain of PH involved in the interaction. Investigations at the structural level might provide indications on the nature of the detailed FH/PH interaction. At present, only one protein interacting with , that is, B. burgdorferi OspE has been determined at the structural level, whereas the structures of three proteins, which bind to SCRs 6-7, have been revealed in detail (59) (60) (61) (62) . Interestingly, no structural resemblance was established between these microbial proteins.
Inhibition of FH recruitment to the surface of H. influenzae was shown to reduce the ability of bacteria to resist serum-mediated killing (21) . We therefore anticipated that PH was an important factor involved in serum resistance. Hib and Hif strains devoid of PH harbored a higher sensitivity to serum killing than their wildtype counterparts and thus confirmed a role for PH in serum resistance. In most cases, microbes bind FH to survive killing by the alternative pathway. Bacteria loaded with FH are, however, still exposed to the other pathways of the complement system. Hence, to avoid serum killing from all pathways, H. influenzae also recruits the complement regulator C4b-binding protein, the major soluble regulator of the classical and the lectin pathway, in addition to vitronectin, which inhibits the formation of the lytic MAC (20, 22, 23, 63) . Another strategy to circumvent the deleterious effects of complement relies on masking the structures which interact with activators of complement. Thus, H. influenzae conceals the LOS by decorating its outer core with sialic acid, phosphorylcholine, or di-galactoside (64-66). These structures mislead the human immune system into recognizing H. influenzae as self and result in a decreased bacterial clearance that is highly FIGURE 6 . Cofactor activity of FH bound to Hib and Hif strains or purified recombinant PH. Hib (A) and Hif (B) wild-type bacteria or corresponding PH deletion mutants were preincubated with FH before incubation in the presence (+) or absence (2) of different combinations of purified factor I (FI) and C3b. The degradation of C3b was detected using an anti-human C3 pAb. Arrows indicate the degradation fragments of C3b. In (C), immobilized PH variants were incubated with a combination of FH, FI, and C3b. The degradation of C3b was monitored using anti-human C3 pAb. The arrows indicate the position of the two intact C3b chains (a9, b) and the degradation fragments (a9 68 kDa, a9 43 kDa, and a9 41 kDa). beneficial for the bacteria. The remaining challenges are to determine the relative part of each mechanism involved in bacterial serum resistance and their possible regulation, in particular at each step of the infection process. H. influenzae isolates collected from different anatomical localizations exhibit a comparable resistance against serum-mediated killing, suggesting that serum resistance is an important trait at every step, that is, bacterial adhesion followed by colonization, and finally invasion (67) (68) (69) . Interestingly, we also showed that the H. influenzae-dependent affinity for complement regulators FH, C4BP and vitronectin was not higher in invasive strains as compared with isolates from the nasopharynx (67) .
In conclusion, we have identified and characterized PH, a previously unknown virulence factor that is located at the surface of H. influenzae serotype b and f. Protein H confers H. influenzae to resist complement-mediated serum killing by binding FH and FHL-1. Because no similarities exist between PH and earlier defined FH-binding proteins in other pathogens there is a need to gather more structural data to uncover the minimal requirements for binding to FH, in particular regarding the interaction that occurs via SCRs 18-20.
